• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Getinge Receives FDA Clearance for Multiple Products

    Study Shows Benefits of CCHD Screening Using Masimo SET Pulse Oximetry

    TEAM Technologies Acquires ViruDefense

    KORU Medical Systems Names New CEO

    Medtronic Receives FDA Approval for Pipeline Flex Embolization Device with Shield Technology
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Home Is Where the Heart (Valve) Is

    CGM: Digital Health Meets a Very Large Opportunity

    Biomechanical Engineer, Heal Thyself

    Optimizing MIM in Medical Device Manufacturing

    PPE and Diagnostics: Sourcing Domestically and Speeding Time to Market
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Creganna Medical, part of TE Connectivity

    Spectrum Plastics Group

    K-Tube Technologies

    Qosina Corp.

    PTI Engineered Plastics Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    OEMs Increasingly Choosing EMS Providers Closer to Home

    EMS' Engineering Resources Increasingly in Demand

    Fiber Optics Introducing New Cleanliness Requirements for Medical Electronics

    EMS Providers Valued for Product Customization, Medical Certification Expertise

    Three Future Trends and Opportunities in Quality Assurance
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Qosina Corp.

    MW Life Sciences

    Trademark Plastics Inc.

    Forefront Medical Technology

    Medbio LLC
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Boston Scientific Acquires U.K.-Based BTG for $4.2B

    BTG develops products used in minimally-invasive procedures targeting cancer and vascular diseases.

    Boston Scientific Acquires U.K.-Based BTG for $4.2B
    Related CONTENT
    • FDA OKs Canon Medical's One-Beat Spectral Cardiac CT
    • Thermo Fisher Scientific to Acquire PPD for $17.4 Billion
    • DiaSorin to Buy Luminex for $1.8B
    • Endologix Acquires PQ Bypass
    • Digging into the Cardiac Arrhythmia Monitoring Device Market
    Boston Scientific11.20.18
    Boston Scientific today announced it has reached an agreement on the terms of a recommended offer to acquire BTG plc., a company headquartered in the United Kingdom, which develops and commercializes products used in minimally-invasive procedures targeting cancer and vascular diseases, as well as acute care pharmaceuticals. 
     
    The transaction has been unanimously approved by the boards of directors of Boston Scientific and BTG. Under the terms of the transaction, holders of BTG's common shares would receive cash consideration of 840 pence per share. The total cash consideration for 100 percent of BTG's equity is approximately £3.3B, or U.S.$4.2B. The transaction is intended to be effected by way of an English court-sanctioned scheme of arrangement and is expected to close in the first half of 2019, subject to receipt of required regulatory approvals and the approval of BTG's shareholders and the U.K. court.
     
    BTG has three key businesses, the largest of which is its Interventional Medicine portfolio which encompasses several peripheral interventional product lines. The interventional oncology franchise includes the TheraSphere Y-90 radiotherapy microspheres and the GALIL cryoablation system, used to treat patients with liver, kidney and other cancers. More than 840,000 people are expected to be diagnosed with liver cancer in 2018, and that number is expected to grow to 1.1 million by 2030.1 Kidney cancer is among the 10 most common cancers in both men and women.2
     
    The company's Interventional Medicine business also has a highly-differentiated vascular portfolio, including filters, crossing catheters, microfoam, and the EKOS Endovascular System. The EKOS system, in combination with clot-dissolving drugs, breaks down blood clots to restore blood flow in patients with pulmonary emboli, deep vein thrombosis, and peripheral arterial occlusions. It was the first device cleared by the Food and Drug Administration for the treatment of pulmonary embolism—a common complication of hospitalization and a leading cause of preventable hospital deaths.3
     
    "The acquisition of BTG and its rapidly growing peripheral interventional portfolio is an exciting extension of our category leadership strategy that will augment our capabilities in important areas of unmet need such as cancer and pulmonary embolism," said Mike Mahoney, chairman and chief executive officer, Boston Scientific. "We are confident that the addition of these therapies to our portfolio will ultimately advance patient care in ways that could not be realized by either company alone, while also allowing us to realize substantial revenue and cost synergies and provide a strong return for investors."
     
    The BTG portfolio also includes a pharmaceutical business comprised of acute care antidotes to treat overexposure to certain medications and toxins, and a licensing business that receives royalties relating to products subject to BTG intellectual property and license agreements. The company has 1,600 employees globally, located in North America, Europe, Asia, and Australia.  
     
    "Boston Scientific shares our commitment to transforming patient care, and has a sustained track record of innovation, clinical expertise, and global commercial capabilities," said Dame Louise Makin, chief executive officer, BTG. "The combined organization will be well positioned for success, enabling our valuable products to make a real difference to more people around the world."
     
    Boston Scientific has received irrevocable undertakings to vote in favor of the transaction from BTG's three largest shareholders, covering an aggregate of approximately 33 percent of BTG's outstanding shares, as well as from all of BTG's directors, who hold an additional 0.3 percent of BTG shares. The transaction would be funded with a combination of cash on hand and proceeds from debt financing entered into by Boston Scientific. The full terms of the proposed transaction, including the full terms of the undertakings from BTG's shareholders and directors, are set forth in an announcement made by Boston Scientific, Bravo Bidco Limited, a wholly-owned Boston Scientific subsidiary formed to effect the proposed transaction, and BTG today in accordance with Rule 2.7 of the U.K.'s City Code on Takeovers and Mergers. Boston Scientific has entered into a bridge financing facility providing for its receipt of £3.3B of committed financing, which satisfies the certain funds requirements of the U.K. Takeover Code.
     
    The transaction is expected to be two to three cents accretive to Boston Scientific adjusted earnings per share in 2019, and increasingly accretive thereafter. On a GAAP basis, the transaction is expected to be dilutive in 2019, and less dilutive or increasingly accretive thereafter, as the case may be, due to amortization expense and acquisition-related net charges.
     
    Barclays and Shearman & Sterling are acting as financial and legal advisors, respectively, on behalf of Boston Scientific. 
     
    References
    1 International Association of Cancer Registries; GLOBOCAN Database: http://gco.iarc.fr/.
    2 American Cancer Society. Key Statistics about Kidney Cancer. https://www.cancer.org/cancer/kidney-cancer/about/key-statistics.html.
    3 American Thoracic Society. Breathing in America: Diseases, Progress and Hope; Chapter 16. https://www.thoracic.org/patients/patient-resources/breathing-in-america/resources/chapter-16-pulmonary-embolism.pdf .
    Related Searches
    • boston scientific
    • cancer
    • mike mahoney
    • track
    Related Knowledge Center
    • Surgical
    • Cardiovascular
    Suggested For You
    FDA OKs Canon Medical FDA OKs Canon Medical's One-Beat Spectral Cardiac CT
    Thermo Fisher Scientific to Acquire PPD for $17.4 Billion Thermo Fisher Scientific to Acquire PPD for $17.4 Billion
    DiaSorin to Buy Luminex for $1.8B DiaSorin to Buy Luminex for $1.8B
    Endologix Acquires PQ Bypass Endologix Acquires PQ Bypass
    Digging into the Cardiac Arrhythmia Monitoring Device Market Digging into the Cardiac Arrhythmia Monitoring Device Market
    Cloud and AI Accelerating Global Medical Imaging Informatics Market Cloud and AI Accelerating Global Medical Imaging Informatics Market
    How Digital Health Fits into the Medtech Mold How Digital Health Fits into the Medtech Mold
    Fralock Holdings Acquires Oasis Materials Fralock Holdings Acquires Oasis Materials
    Bassetti Acquires 3DTRUST Bassetti Acquires 3DTRUST
    Philips Debuts AI-Enabled CT Workflow Solution Philips Debuts AI-Enabled CT Workflow Solution
    Boston Scientific to Pay $189M to Settle Charges Over Surgical Mesh Boston Scientific to Pay $189M to Settle Charges Over Surgical Mesh
    Global Medtech Industry Cross-Border M&A Deals Total $4.5B in Q4 2020 Global Medtech Industry Cross-Border M&A Deals Total $4.5B in Q4 2020
    J. Knipper and Company Appoints Chief Financial Officer J. Knipper and Company Appoints Chief Financial Officer
    CSI Buys Peripheral Support Catheters from WavePoint Medical CSI Buys Peripheral Support Catheters from WavePoint Medical
    U.S. Safety Needles Market to Top $3.4B by 2028 U.S. Safety Needles Market to Top $3.4B by 2028

    Related Breaking News

    • Cardiovascular
      Riva Health Raises $15.5 Million for Breakthrough Mobile Cardiology Technology

      Riva Health Raises $15.5 Million for Breakthrough Mobile Cardiology Technology

      Menlo Ventures, UCHealth invest to bring comprehensive hypertension measurement and management to the phone.
      Michael Barbella, Managing Editor 04.20.21

    • Cardiovascular
      FDA OKs Canon Medical

      FDA OKs Canon Medical's One-Beat Spectral Cardiac CT

      Aquilion ONE / PRISM Edition now offers AI-powered spectral capabilities for cardiac exams.
      Sam Brusco, Associate Editor 04.19.21

    • Cardiovascular | Software & IT
      BioSig Launches Software Update for PURE EP Electrophysiology Platform

      BioSig Launches Software Update for PURE EP Electrophysiology Platform

      The upgrade includes enhanced signal processing for advanced cardiac signal analysis.
      Sam Brusco, Associate Editor 04.14.21


    • Surgical
      Katena Acquires Ophthalmic Surgical Instrument Maker ASICO

      Katena Acquires Ophthalmic Surgical Instrument Maker ASICO

      Katena obtains high-quality ophthalmic surgical instruments.
      Sam Brusco, Associate Editor 04.14.21

    • Cardiovascular
      Endologix Acquires PQ Bypass

      Endologix Acquires PQ Bypass

      Gains proprietary Detour platform for percutaneous femoral-popliteal bypass.
      Sam Brusco, Associate Editor 04.13.21

    • Cardiovascular
      Elixir Medical Begins Study of Metallic Implant for CAD Treatment

      Elixir Medical Begins Study of Metallic Implant for CAD Treatment

      Product is designed to adapt to vessel physiology.
      Michael Barbella, Managing Editor 04.13.21


    • Cardiovascular
      USPTO Issues Patent Covering Hancock Jaffe’s VenoValve

      USPTO Issues Patent Covering Hancock Jaffe’s VenoValve

      Valve is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency (CVI).
      Charles Sternberg, Assistant Editor 04.08.21

    • Cardiovascular | Surgical
      Abbott

      Abbott's Next-Gen TriClip Earns EU Nod

      New enhancements to first-of-its-kind device uniquely developed for the difficult-to-treat tricuspid valve.
      Sam Brusco, Associate Editor 04.08.21

    • Surgical
      Bausch + Lomb

      Bausch + Lomb's ClearVisc Dispersive Ophthalmic Viscosurgical Device Approved

      Offers corneal protection and visibility during ophthalmic surgery.
      Sam Brusco, Associate Editor 04.07.21


    • Surgical
      Royal Philips’ SmartCT Application Software Receives FDA 510(k) Clearance

      Royal Philips’ SmartCT Application Software Receives FDA 510(k) Clearance

      Helps enhance clinical confidence, smooths workflows, and increases productivity.
      Charles Sternberg, Assistant Editor 04.06.21

    • Surgical
      Ethicon Launches Echelon+ Stapler

      Ethicon Launches Echelon+ Stapler

      Increases staple line security and reduces complications in surgery.
      Charles Sternberg, Assistant Editor 04.01.21

    • Cardiovascular | Patient Monitoring
      GE Healthcare Reveals Venue Fit POC Ultrasound with Cardiac AI Tool

      GE Healthcare Reveals Venue Fit POC Ultrasound with Cardiac AI Tool

      AI tool continuously calculates the heart’s real-time ejection fraction.
      Sam Brusco, Associate Editor 03.31.21


    • Cardiovascular
      Heart Failure Treatment Using Electrical Microcurrent Shows Promise

      Heart Failure Treatment Using Electrical Microcurrent Shows Promise

      Berlin Heals' C-MIC device restores endogenous electric potential gradients using microcurrents, leading to improved myocardial function.
      Michael Barbella, Managing Editor 03.30.21

    • Cardiovascular
      FDA Breakthrough Status Granted to Cook Medical

      FDA Breakthrough Status Granted to Cook Medical's Zenith Endovascular Graft

      ZFEN+ includes up to five precisely located fenestrations to accommodate the visceral vessels.
      Michael Barbella, Managing Editor 03.29.21

    • Cardiovascular
      FDA Approves Medtronic

      FDA Approves Medtronic's Harmony TPV for Congenital Heart Disease

      Less invasive option to treat pulmonary valve regurgitation for patients with a native or surgically-repaired right ventricular outflow tract.
      Sam Brusco, Associate Editor 03.26.21


    Trending
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • J&J’s Veritas Vision System Receives FDA Clearance And CE Mark
    • Top 10 Trends In The Medical Device And Equipment Industry
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • Johnson & Johnson Vision Unveils Acuvue Abiliti
    Breaking News
    • Getinge Heart Lung Machine Becomes Available for European Hospitals
    • Getinge Receives FDA Clearance for Multiple Products
    • Study Shows Benefits of CCHD Screening Using Masimo SET Pulse Oximetry
    • TEAM Technologies Acquires ViruDefense
    • KORU Medical Systems Names New CEO
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Transporting Treatment: An Examination of Tubing Technologies
    • Face to (Virtual) Face: Telemedicine Now and Post-Pandemic
    • Outward Appearance: Reviewing Surface Treatment Options
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Ashland Supports the Nature Conservancy Forest Restoration Effort to Help Plant a Billion Trees
    Martin Bauer Announces Installation of Agile Filling System at Bethlehem, PA Facility
    PepsiCo and Ingredion Begin Pilot Partnership with Soil and Water Outcomes Fund
    Coatings World

    Latest Breaking News From Coatings World

    Axalta Wins Three 2021 Edison Awards
    AkzoNobel Shareholders Approve Final Dividend at Annual General Meeting
    PPG Maintains EcoVadis Gold Rating
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Getinge Heart Lung Machine Becomes Available for European Hospitals
    Getinge Receives FDA Clearance for Multiple Products
    Study Shows Benefits of CCHD Screening Using Masimo SET Pulse Oximetry
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Lonza to Build Small Molecule Manufacturing Complex in Visp
    RDIF, Minapharm to Make Over 40M Doses of the Sputnik V Vaccine in Egypt
    Bora Pharmaceuticals Completes Health Canada Inspection
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Love Beauty and Planet Announces Sustainability Initiatives
    Coty Shares Long-Term Strategy
    Johnson & Johnson Reports Sales Increase in First Quarter of 2021
    Happi

    Latest Breaking News From Happi

    Pravana Joins PETA’s Beauty without Bunnies Program
    A New Chief Digital Officer at L'Oréal
    CEW Seeks Entries for Beauty Creators Awards
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    SE-DA Invests in Kornit Presto S
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Ravenwood introduces water resistant linerless paper
    Ashland commits to forest restoration
    Epson upgrades SurePress demo facility
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Fibertex Nonwovens Announces European Investments
    Savaré Strengthens Technical Support for the Americas
    FiberVisions, Avgol Partner with Polymateria
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA Clears Orthofix's 3D-Printed FORZA Titanium TLIF Spacer System
    Patients Conclude Clinical Visits in Knee Osteoarthritis Treatment Study
    SeaSpine Begins Limited Rollout of WaveForm TO 3D-Printed Interbodies
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Identiv, Ameta International Announce US, Canadian Distribution Partnership
    Adesis Achieves ISO 9001:2015 Certification
    Louis Widmer SA Complies with EU Anti-Counterfeiting Directive with Zebra Technologies’ Solution

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login